Cardiff Oncology, Inc. (CRDF)
NASDAQ: CRDF · Real-Time Price · USD
1.250
-0.100 (-7.41%)
At close: Jul 8, 2026, 4:00 PM EDT
1.240
-0.010 (-0.80%)
After-hours: Jul 8, 2026, 4:51 PM EDT
Cardiff Oncology Market Cap
Cardiff Oncology has a market cap or net worth of $85.46 million as of July 8, 2026. Its market cap has decreased by -59.34% in one year.
Market Cap
85.46M
Enterprise Value
41.42M
1-Year Change
-59.34%
Ranking
Category
Stock Price
$1.25
Market Cap Chart
Since May 29, 2012, Cardiff Oncology's market cap has increased from $56.00M to $85.46M, an increase of 52.61%. That is a compound annual growth rate of 3.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 8, 2026 | 85.46M | -54.85% |
| Dec 31, 2025 | 189.30M | -14.69% |
| Dec 31, 2024 | 221.90M | 235.70% |
| Dec 29, 2023 | 66.10M | 5.76% |
| Dec 30, 2022 | 62.50M | -73.71% |
| Dec 31, 2021 | 237.70M | -62.60% |
| Dec 31, 2020 | 635.50M | 6,519.79% |
| Dec 31, 2019 | 9.60M | -20.66% |
| Dec 31, 2018 | 12.10M | 3.42% |
| Dec 29, 2017 | 11.70M | -81.80% |
| Dec 30, 2016 | 64.30M | -59.94% |
| Dec 31, 2015 | 160.50M | 97.42% |
| Dec 31, 2014 | 81.30M | -25.07% |
| Dec 31, 2013 | 108.50M | 10.38% |
| Dec 31, 2012 | 98.30M | 75.54% |
| May 29, 2012 | 56.00M | - |
View and export this data all the way back to 2012. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Gossamer Bio | 95.28M |
| Adicet Bio | 95.24M |
| ImmuCell | 92.14M |
| MAIA Biotechnology | 88.77M |
| NeurAxis | 88.67M |
| Telomir Pharmaceuticals | 87.34M |
| Pelthos Therapeutics | 84.56M |
| Entera Bio | 84.18M |